Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 428

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 428
---
 price and number of shares issuable upon exercise of the warrants
may be adjusted in certain circumstances including in the event of a share dividend, or the Company’s recapitalization, reorganization,
merger or consolidation. However, the warrants will not be adjusted for issuances of shares at a price below its exercise price. The Company
will have no obligation to net cash settle the exercise of the warrants. The holder of the warrants will not be entitled to exercise the
warrants for cash unless a registration statement covering the securities underlying the warrants is effective or an exemption from registration
is available.

Merger Agreement

On November 7, 2022, NorthView
entered into a Merger Agreement and Plan of Reorganization (the “Merger Agreement”), by and among Merger Sub., and Profusa,
Inc., a California corporation (“Profusa”). The Merger Agreement provides that, among other things, at the closing of the
transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Profusa (the “Merger”), with Profusa
surviving as a wholly-owned subsidiary of NorthView.

At the Special Meeting held
on June 9, 2025, the Company’s stockholders voted to approve the proposals outlined in the Proxy Statement/Prospectus, including,
among other things, the adoption of the Merger Agreement and approval of the transactions contemplated by the Merger Agreement, including
the merger of Merger Sub with and into Profusa, with Profusa continuing as the surviving corporation and as a wholly-owned subsidiary
the Company, and the issuance of the Company’s common stock as consideration thereunder. On July 11, 2025, the Closing was
completed.

In connection with the Closing,
the Company changed its name to “Profusa, Inc.”

<div align='center'>F-101

NORTHVIEW ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div>

Note 6 — Commitments and Contingencies
(cont.)

Advisory Agreements

On December 19,
2024, the Company engaged A.G.P to serve as the placement agent in connection with a proposed business combination transaction. The
Company shall pay to A.G.P. a cash fee (the “Cash Fee”) equal to 9.0% in a convertible note offering, note, or other
similar equity-linked offerings, and shall be calculated from the face value of notes issued, which